205 related articles for article (PubMed ID: 31882595)
21. Inhibition of tooth eruption in the rat by a bisphosphonate.
Grier RL; Wise GE
J Dent Res; 1998 Jan; 77(1):8-15. PubMed ID: 9437395
[TBL] [Abstract][Full Text] [Related]
22. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice.
Lee K; Kim H; Park HS; Kim KJ; Song H; Shin HI; Kim HS; Seo D; Kook H; Ko JH; Jeong D
J Immunol; 2013 Feb; 190(4):1623-30. PubMed ID: 23303667
[TBL] [Abstract][Full Text] [Related]
23. Diverse effects of c-src deficiency on molar tooth development and eruption in mice.
Miyata A; Baba O; Oda T; Ishikawa I; Takano Y
Arch Histol Cytol; 2007 Apr; 70(1):63-78. PubMed ID: 17558145
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth.
Qin H; Yang FS
Med Hypotheses; 2008; 70(5):1048-50. PubMed ID: 18023993
[TBL] [Abstract][Full Text] [Related]
25. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
26. Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice.
Kuritani M; Sakai N; Karakawa A; Isawa M; Chatani M; Negishi-Koga T; Funatsu T; Takami M
Biol Pharm Bull; 2018; 41(4):637-643. PubMed ID: 29607937
[TBL] [Abstract][Full Text] [Related]
27. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling.
Li S; Liu Q; Wu D; He T; Yuan J; Qiu H; Tickner J; Zheng SG; Li X; Xu J; Rong L
Cell Death Dis; 2020 Sep; 11(9):762. PubMed ID: 32938907
[TBL] [Abstract][Full Text] [Related]
28. PTH intermittent administration may be a useful therapeutic agent to avoid premature eruption of the tooth.
Vasconcelos DF; Vasconcelos AC
Med Hypotheses; 2016 Mar; 88():27-9. PubMed ID: 26880630
[TBL] [Abstract][Full Text] [Related]
29. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model.
Korn P; Kramer I; Schlottig F; Tödtman N; Eckelt U; Bürki A; Ferguson SJ; Kautz A; Schnabelrauch M; Range U; Kneissel M; Stadlinger B
Eur Cell Mater; 2019 May; 37():333-346. PubMed ID: 31112281
[TBL] [Abstract][Full Text] [Related]
30. Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats.
Hiraga T; Ninomiya T; Hosoya A; Nakamura H
Calcif Tissue Int; 2010 Jun; 86(6):502-10. PubMed ID: 20411381
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone receptor and insulin-like growth factor-I immunoreactivity in osteoclast-like cells during tooth eruption in the toothless (osteopetrotic) rat following treatment with colony-stimulating factor-1.
Symons AL; Weerakoon A; Marks SC
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):195-204. PubMed ID: 14696967
[TBL] [Abstract][Full Text] [Related]
32. Periodontal ligament-associated protein-1 gets involved in the development of osseous eruption canal.
Yu X; Liu H; Li C; Du Y; Du Y; Zhang S
J Mol Histol; 2019 Feb; 50(1):35-42. PubMed ID: 30511172
[TBL] [Abstract][Full Text] [Related]
33. Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone.
Cappariello A; Loftus A; Muraca M; Maurizi A; Rucci N; Teti A
J Bone Miner Res; 2018 Mar; 33(3):517-533. PubMed ID: 29091316
[TBL] [Abstract][Full Text] [Related]
34. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue.
Ogasawara T; Yoshimine Y; Kiyoshima T; Kobayashi I; Matsuo K; Akamine A; Sakai H
J Periodontal Res; 2004 Feb; 39(1):42-9. PubMed ID: 14687227
[TBL] [Abstract][Full Text] [Related]
35. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
36. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways.
Peng Y; Liu Q; Xu D; Li K; Li H; Qiu L; Lin J
Cell Biol Int; 2021 May; 45(5):1015-1029. PubMed ID: 33404170
[TBL] [Abstract][Full Text] [Related]
38. Effect of periostin silencing on Runx2, RANKL and OPG expression in osteoblasts.
Cai J; Qin H; Yu G
J Orofac Orthop; 2021 Mar; 82(2):82-91. PubMed ID: 33141273
[TBL] [Abstract][Full Text] [Related]
39. Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression.
Lin W; Li XF; Ren DC; Song M; Duan L; Liu JZ; Zhan ZR
Mol Med; 2021 Feb; 27(1):19. PubMed ID: 33637048
[TBL] [Abstract][Full Text] [Related]
40. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
